Showing posts with label breast cancer screening. Show all posts
Showing posts with label breast cancer screening. Show all posts

Wednesday, May 5, 2010

How to Improve Pancreatic Cancer Life Expectancy

How to Improve Pancreatic Cancer Life Expectancy


Pancreatic cancer is a disease that primarily affects the pancreas. The pancreas is mostly located in the interior parts below the abdomen and the stomach. The pancreas is essential because it releases enzymes to catalyze the digestion process, and also helps maintain blood sugar levels stable.
Sadly, pancreatic cancer is rarely detected, and an effective treatment can be difficult to find. The symptoms of pancreatic cancer are usually felt at the peak of the disease—which gives the patient very little time to find a treatment.
The life expectancy of individuals who are diagnosed with pancreatic cancer is usually about five to eight months. Albeit pancreatic cancer life expectancy is very low, it is still possible to prolong the life expectancy of pancreatic cancer. The following information below shows a detailed guide on how to increase pancreatic cancer life expectancy, and how to treat pancreatic cancer symptoms.



Read more at Suite101: How to Improve Pancreatic Cancer Life Expectancy http://cancer.suite101.com/article.cfm/how-to-improve-pancreatic-cancer-life-expectancy#ixzz0n2bUupVV

Tuesday, April 13, 2010

Immunomedics to Report on Potential Cancer Therapy Products in 8 Presentations at 101st Annual AACR Meeting - MarketWatch

Immunomedics to Report on Potential Cancer Therapy Products in 8 Presentations at 101st Annual AACR Meeting - MarketWatch

MORRIS PLAINS, N.J., Apr 12, 2010 (GlobeNewswire via COMTEX) -- Immunomedics, Inc. /quotes/comstock/15*!immu/quotes/nls/immu (IMMU 3.69, +0.12, +3.36%) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that eight presentations reporting on the Company's progress in diverse cancer therapy product candidates will be given at the 101st Annual Meeting of the American Association for Cancer Research (AACR), April 17 -- 21, 2010, in Washington, DC.
The spotlight of this year's presentations will be on pancreatic cancer, highlighted by a study correlating the results from a blood test for pancreatic cancer detection with responses to a radiolabeled antibody therapy. Additionally, the Company will introduce new antibody-drug conjugates (ADC) being studied in this cancer. (Please refer to the Company's press release at www.immunomedics.com/news_pdf/2010_PDF/PR01212010.pdf for more information on the new blood test).

Posted using ShareThis